Lurasidone was up titrated to 120mg. Lithium was also continued,
with plans to discontinue the medication as an outpatient after
achieving a period of stability on lurasidone. The patient’s symptoms
improved steadily as lurasidone was increased to therapeutic levels.
The patient tolerated the medication well and reported no adverse
effects. By the end of her 10-day admission, the patient’s delusions
had fully remitted, and she demonstrated insight into the false nature
of her beliefs